EPI-743 conference call scheduled

Conference Call with Edison for those who are interested in EPI-743 has been scheduled.
Friday, April 5
Noon eastern time/9 am Pacific

More details:
An update from Edison Pharma on the Development of the EPI-743

Join us for a very important discussion with leaders from Edison Pharma about the EPI-743
clinical trial for children with Leigh Syndrome.

Topics for this call include:

1. Status on EPI-743 clinical development
2. Status on EPI-743 US clinical trials
3. Status on EPI-743 European clinical trials

Q&A opportunity included in this important discussion. Parents, patients and families - please join us!


To join the online event-------------------------------------------------------
Go to : https://umdf.webex.com/umdf/onstage/g.php?d=667321101&t=a
Fill in your name/email
Click JOIN NOW

To hear the audio portion, do the following:
Call-in toll number (US/Canada):1-650-479-3207
Global call-in numbers:https://umdf.webex.com/umdf/globalcallin.php?serviceType=EC&ED=105951307&tollFree=0

Access code: 667 321 101
You will be given an “Attendee ID” to use and you will be placed into conference.

-------------------------------------------------------
To join the teleconference only
-------------------------------------------------------
To hear the audio portion, do the following:
Call-in toll number (US/Canada):1-650-479-3207
Global call-in numbers:https://umdf.webex.com/umdf/globalcallin.php?serviceType=EC&ED=105951307&tollFree=0
Access code: 667 321 101
You will be given an “Attendee ID” to use and you will be placed into conference.


Please send questions in advance to info@mitoaction.org or connect@umdf.org